Evidence map›Paper›PMID 33141139›Full record

ReviewOrganic & biomolecular chemistry2020

Tyrosine bioconjugation - an emergent alternative.

Peter A Szijj, Kristina A Kostadinova, Richard J Spears, Vijay Chudasama

Erratum issuedAbstract readReview
In one paragraph

Review in Organic & biomolecular chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Methods for Conjugating Antibodies with Quantum Dots.Molecules (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Article
  8. Amyloid-reoriented enzyme catalysis.Nature communications · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Site-Selective Tyrosine Reaction for Antibody-Cell Conjugation and Targeted Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Enlarging the scenario of site directedScientific reports · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Peter A SzijjDepartment of Chemistry, University College London, London, UK. v.chudasama@ucl.ac.uk.
Kristina A KostadinovaDepartment of Chemistry, University College London, London, UK. v.chudasama@ucl.ac.uk.ORCID 0000-0003-2804-5924
Richard J SpearsDepartment of Chemistry, University College London, London, UK. v.chudasama@ucl.ac.uk.
Vijay ChudasamaDepartment of Chemistry, University College London, London, UK. v.chudasama@ucl.ac.uk.ORCID 0000-0002-8876-3285

Funding

Wellcome Trust
6 · The paper itself

Abstract

Protein bioconjugation is an increasingly important field of research, with wide-ranging applications in areas such as therapeutics and biomaterials. Traditional cysteine and lysine bioconjugation strategies are widely used and have been extensively researched, but in some cases they are not appropriate and alternatives are needed or they are not compatible with one another to enable the formation of dually (and distinctly) modified dual-conjugates (an increasingly desired class of bioconjugates). Here we review the heretofore less explored approach of tyrosine bioconjugation, which is rapidly becoming a constructive alternative/complement to the more well-established strategies. Herein we present an overview of the field, and then focus on promising recent methods that can achieve high conversion and chemoselectivity. This suggests that not only can tyrosine bioconjugation be used in conjunction with cysteine and lysine modification to obtain proteins with multiple different modifications, it is also becoming a stand-alone alternative to these more traditional methods.

Indexed as

ProteinsTyrosineCysteineHumansLysineCysteineLysineProteinsTyrosine

Identifiers

PMID33141139
PMCPMC7814872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.